News

Published on 5 Oct 2021 on Benzinga via Yahoo Finance

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin...


Article preview image

Here's a roundup of top developments in the biotech space over the last 24 hours:

Scaling The Peaks

NASDAQ.TCRR price evolution
NASDAQ.HZNP price evolution
NASDAQ.NBRV price evolution
NASDAQ.PSTX price evolution
NASDAQ.ENSC price evolution
NASDAQ.ARAV price evolution
NASDAQ.AVRO price evolution
NASDAQ.ONTX price evolution
NASDAQ.BDTX price evolution
NASDAQ.LTRN price evolution
NASDAQ.GLTO price evolution
NASDAQ.ADTX price evolution
NASDAQ.VRTX price evolution
NASDAQ.INCY price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Incyte Corporation (NASDAQ:INCY) Yearly Results Just Came Out: Here's What Analysts Are Forecasting...

As you might know, Incyte Corporation (NASDAQ:INCY) recently reported its yearly numbers. Results...

Simply Wall St. via Yahoo Finance 15 Feb 2024

Incyte downgraded amid missed acquisition opportunity

On Wednesday, JMP Securities adjusted its stance on Incyte (NASDAQ: INCY ) Corporation...

Investing.com 14 Feb 2024

Earnings call: Incyte reports record $1 billion in Q4 with strong pipeline

Incyte Corporation (NASDAQ: INCY ) delivered a robust performance in the fourth quarter of 2023,...

Investing.com 13 Feb 2024

Incyte Corporation (NASDAQ:INCY) Q4 2023 Earnings Call Transcript

Incyte Corporation (NASDAQ:INCY) Q4 2023 Earnings Call Transcript February 13, 2024 Incyte Corpor...

Insider Monkey via Yahoo Finance 13 Feb 2024

Drug, Biotech Stocks' Q4 Earnings Due on Feb 13: BIIB, ZTS & INCY

The fourth-quarter earnings season for the drug and biotech sector is almost halfway through. Mos...

Zacks via Yahoo Finance 12 Feb 2024

Incyte (INCY) to Report Q4 Earnings: What's in the Cards?

Incyte Corporation INCY is scheduled to release fourth-quarter and full-year 2023 results on Feb ...

Zacks via Yahoo Finance 9 Feb 2024

Is Incyte Corporation's (NASDAQ:INCY) Recent Stock Performance Influenced By Its Fundamentals In Any...

Incyte (NASDAQ:INCY) has had a great run on the share market with its stock up by a significant 1...

Simply Wall St. via Yahoo Finance 23 Jan 2024

Investors in Incyte (NASDAQ:INCY) from three years ago are still down 34%, even after 4.4% gain this...

In order to justify the effort of selecting individual stocks, it's worth striving to beat the re...

Simply Wall St. via Yahoo Finance 5 Nov 2023

Earnings call: Incyte reports double-digit revenue growth in Q3 2023, advances in clinical...

Earnings call: Incyte reports double-digit revenue growth in Q3 2023, advances in clinical...

Investing.com 1 Nov 2023

Incyte (INCY) Beats on Q3 Earnings, Misses Revenue Estimates

Incyte Corporation INCY reported third-quarter 2023 adjusted earnings of $1.10 per share, which b...

Zacks via Yahoo Finance 31 Oct 2023